货号: CM-0353
Price: ¥650
产品信息
产品简介 | hFOB 1.19细胞专用培养基由普诺赛技术团队精心优化,经过长期测试,本产品可保持hFOB 1.19细胞最佳的生长状态。本产品中已包含hFOB 1.19细胞生长所需的各种成分,无需添加任何成分,可直接用于hFOB 1.19细胞的体外培养。本产品仅供进一步科研使用,不得用于诊断、治疗、临床、家庭及其它用途。 |
产品形态 | 液体 |
产品浓度 | 1× |
产品规格 | 125mL×4 |
PH | 7.4-7.8 |
培养基成分 | DMEM/F12+0.3mg/mlG418+10%FBS+1%P/S |
细菌检测 | Negative |
真菌检测 | Negative |
支原体检测 | Negative |
细胞生长实验 | The cells are growing well and exhibit normal morphology. |
内毒素含量(EU/mL) | <3 |
储存条件 | 2-8℃,避光储存 |
运输条件 | 冰袋运输 |
有效期 | 3个月 |
注意事项 |
|
-
Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes(2024)
作者:Mingyi Yang, Yani Su, Ke Xu, Haishi Zheng, Yongsong Cai, Pengfei Wen, Zhi Yang, Lin Liu, Peng Xu
期刊:Journal of Immunology Research
影响因子:4.1
引用产品: 143B 细胞, U-2 OS [U2OS] 细胞, hFOB 1.19 细胞, 143B细胞专用培养基, U-2 OS [U2OS]细胞专用培养基, hFOB 1.19细胞专用培养基
-
RBM15-mediated the m6A modification of MAT2A promotes osteosarcoma cell proliferation, metastasis and suppresses ferroptosis(2024)
作者:Huang Zhong, Chen Pengcheng, Liu Yiheng
期刊:MOLECULAR AND CELLULAR BIOCHEMISTRY
DOI:10.1007/s11010-024-05149-z
影响因子:3.5
引用产品: hFOB 1.19细胞专用培养基
-
Beauvericin suppresses the proliferation and pulmonary metastasis of osteosarcoma by selectively inhibiting TGFBR2 pathway(2023)
作者:Geni Ye, Yubo Jiao, Lijuan Deng, Minjing Cheng, Sheng Wang, Junqiu Zhang, Jie Ouyang, Yong Li, Yuxin He, Zhengchao Tu, Zhen Wang, Xiaojuan Song, Chenran Wang, Qi Qi, Dongmei Zhang, Lei Wang, Maohua Huang, Wencai Ye, Minfeng Chen
期刊:International Journal of Biological Sciences
影响因子:9.2
引用产品: hFOB 1.19 细胞, hFOB 1.19细胞专用培养基
-
Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6(2023)
作者:Hanji Huang, Dejie Lu, Kanglu Li, Mingjun Zheng, Xiong Qin, Xiaofei Cui, Ying Chen, Chaotao Chen, Nanchang Huang, Li Zheng, Jinmin Zhao, Bo Zhu
期刊:BIOCHEMICAL PHARMACOLOGY
影响因子:5.8
引用产品: hFOB 1.19 细胞, hFOB 1.19细胞专用培养基
-
Interaction gene set between osteoclasts and regulatory CD4+ T cells can accurately predict the prognosis of patients with osteosarcoma(2023)
作者:Feicui Li, Haijun Tang, Xiaoting Luo, Xiangde Li, Kai Luo, Shangyu Liu, Jiming Liang, Shijie Liao, Chaoyi Zhong, Xinli Zhan, Qingjun Wei, Wenyu Feng, Yun Liu
期刊:CANCER SCIENCE
影响因子:5.7
引用产品: hFOB 1.19细胞专用培养基

识别码示意图